Global COVID-19 Diagnostic Market Report 2024 -2029: A New Very Large and Sustainable Market for Covid Related Diagnostics is Emerging [Yahoo! Finance]
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility [Yahoo! Finance]
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
Co-Diagnostics, Inc. (NASDAQ: CODX) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.50 price target on the stock.
Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]